Characteristics | Values, N (%) |
N | 179 |
Body mass index, kg/m2, median (range) | 29.2 (17.7–46.1) |
Obesity* | 72 (40.2%) |
Age, years, median (range) | 31 (21–43) |
Co-morbidity | |
Polycystic ovary syndrome | 40 (22.3%) |
Endometriosis | 9 (5.0%) |
Histology | |
Atypical endometrial hyperplasia | 60 (33.5%) |
Endometrial carcinoma | 119 (66.5%) |
Regimen | |
GnRHa+LNG-IUD | 107 (59.8%) |
GnRHa+aromatase inhibitors | 72 (40.2%) |
*Body mass index ≥30 kg/m2.
GnRHa, gonadotropin-releasing hormone agonist; LNG-IUD, levonorgestrel-releasing intra-uterine device.